subscribeSubscribe
First Patient In LYNX-2 Phase 3 For Phentolamine After Eye Surgery

First Patient In LYNX-2 Phase 3 For Phentolamine After Eye Surgery
GLOBENEWSWIRE
11 Apr 2024
Share Share
Viatris launches RYZUMVl 0.75% in US

Viatris launches RYZUMVl 0.75% in US
INDIANPHARMAPOST
02 Apr 2024
Share Share
Viatris and Ocuphire`s dilation eye drop Ryzumvi wins FDA nod

Viatris and Ocuphire`s dilation eye drop Ryzumvi wins FDA nod
Fraiser Kansteiner FIERCE PHARMA
27 Sep 2023
Share Share
Enforcement Report - Week of January 18, 2023

Enforcement Report - Week of January 18, 2023
FDA
18 Jan 2023
Share Share
MD Pharmaceutical Supply, LLC Receives FDA Warning Letter

MD Pharmaceutical Supply, LLC Receives FDA Warning Letter
FDA
28 Dec 2022
Share Share
Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol NDA from FDA

Ocuphire Pharma Receives PDFUA Fee Waiver for Nyxol NDA from FDA
GLOBENEWSWIRE
12 Sep 2022
Share Share
Enforcement Report - Week Of June 01, 2022

Enforcement Report - Week Of June 01, 2022
FDA
01 Jun 2022
Share Share
Enforcement Report - Week of March 23, 2022

Enforcement Report - Week of March 23, 2022
FDA
23 Mar 2022
Share Share
Enforcement Report - Week of November 17, 2021

Enforcement Report - Week of November 17, 2021
FDA
17 Nov 2021
Share Share
Enforcement Report - Week of March 11, 2020

Enforcement Report - Week of March 11, 2020
FDA
12 Mar 2020
Share Share